Abstract
Single doses of triphenyl phosphite (TPP), a triester of trivalent phosphorus, cause ataxia and paralysis in hens. Characteristics of neurotoxicity were described as somewhat different from organophosphate induced delayed polyneuropathy (OPIDP), which is caused by triesters of pentavalent phosphorus. The onset of TPP neuropathy was reported to occur earlier than that of OPIDP (5–10 versus 7–14 days after dosing, respectively), and chromatolysis, neuronal necrosis and lesions in certain areas of the brain were found in TPP neuropathy only. Pretreatment with phenylmethanesulfonyl fluoride (PMSF) protects from OPIDP, but it either partially protected from effects of low doses or exacerbated those of higher doses of TPP. In order to account for these differences with OPIDP, it was suggested that TPP neuropathy results from the combination of two independent mechanisms of toxicity: typical OPIDP due to inhibition of neuropathy target esterase (NTE) plus a second neurotoxicity related with other target(s). We explored TPP neuropathy in the hen with attention to the phenomena of promotion and protection which are both caused by PMSF when given in combination with typical neuropathic OPs. When PMSF is given before neuropathic OPs it protects from OPIDP; when given afterwards it exaggerates OPIDP. The former effect is due to interactions with NTE, the latter to interactions with an unknown site. The time course of NTE reappearance after TPP (60 or 90 mg/kg i.v.) inhibition showed a longer half-life when compared to that after PMSF (30 mg/kg s.c.) (10–15 versus 4–6 days, respectively). The clinical signs of TPP neuropathy (60 or 90 mg/kg i.v.) were similar to those observed in OPIDP, appeared 7–12 days after treatment, correlated with more than 70% NTE inhibition/aging and were preceded by a reduction of retrograde axonal transport in sciatic nerve of hens. TPP (60 mg/kg i.v.) neuropathy was promoted by PMSF (120 mg/kg s.c.) given up to 12 days afterwards and was partially protected by PMSF (10–120 mg/kg s.c.) when given 24 h before TPP (60 or 90 mg/kg i.v.). The previously reported early onset of TPP neuropathy might be related to the higher dose used in those experiments and to the resulting more severe neuropathy. The lack of full protection might be explained by the slow kinetics of TPP, which would cause substantial NTE inhibition when PMSF effects on NTE had subsided. Since PMSF also affects the promotion site when given before initiation of neuropathy, the resulting neuropathy would then be due to both protection from and promotion of TPP effects by PMSF. No promotion by PMSF (120 mg/kg s.c.) was observed in TPP neuropathy (90 mg/kg i.v.) partially protected by PMSF (10–30 mg/kg s.c.) This might also be explained by the concurrent effects on NTE and on the promotion site obtained with PMSF pretreatment. We conclude that TPP neuropathy in the hen is likely to be the same as typical OPIDP. The unusual effects of combined treatment to hens with TPP and PMSF are explained by the prolonged pharmacokinetics of TPP and by the dual effect of PMSF i.e. protection from and promotion of OPIDP.
Similar content being viewed by others
References
Abou-Donia MB (1983) Organophosphorus ester-induced delayed neurotoxicity. Annu Rev Pharmacol Toxicol 21: 511–548
Abou-Donia MB, Graham DG (1979) Delayed neurotoxicity of O-ethyl O-4-nitrophenyl phenylphosphonothioate: toxic effects of a single oral dose on the nervous system of hens. Toxicol Appl Pharmacol 48: 57–66
Abou-Donia MB, Lapadula DM (1990) Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Ann Rev Pharmacol Toxicol 30: 405–440
Abou-Donia MB, Graham DG, Timmons PR, Reichert BL (1979) Delayed neurotoxic and late acute effects of S,S,S-tributyl phosphorotrithioate on the hen: effect of route of administration. Neurotoxicology 1: 425–447
Bickford AA, Sprague GL (1983) The significance of background neurologic lesions in acute delayed neurotoxicity studies: a comparison of neurohistopathologic lesions induced in commercial hens by tri-o-tolyl phosphate (TOCP) with those observed in negative control hens. Neurotoxicology 4: 283–310
Carrington CD, Abou-Donia MB (1988) Triphenyl phosphite neurotoxicity in the hen: inhibition of neurotoxic esterase and prophylaxis by phenylmethylsulfonyl fluoride. Arch Toxicol 62: 375–380
Carrington CD, Brown HR, Abou-Donia MB (1988) Histopathological assessment of triphenyl phosphite neurotoxicity in the hen. Neurotoxicology 9: 223–234
Johnson MK (1977) Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 37: 113–115
Johnson MK, Read DJ (1987) The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and protective effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo. Toxicol Appl Pharmacol 90: 103–115
Knoth-Anderson J, Veronesi B, Jones K, Lapadula DM, Abou-Donia MB (1992) Triphenyl phosphite-induced ultrastructural changes in bovine adrenomedullary chromaffin cells. Toxicol Appl Pharmacol 112: 110–119
Konno N, Katoh K, Yamauchi T, Fukushima M (1989) Delayed neurotoxicity of triphenyl phosphite in hens: pharmacokinetic and biochemical studies. Toxicol Appl Pharmacol 100: 440–450
Lotti M (1992) The pathogenesis of organophosphate delayed polyneuropathy. Crit Rev Toxicol 21: 465–487
Lotti M, Caroldi S, Capodicasa E, Moretto A (1991) Promotion of organophosphate induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol Appl Pharmacol 108: 234–241
Lotti M, Moretto A, Capodicasa E, Bertolazzi M, Peraica M, Scapellato ML (1993) Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 122: 165–171
Moretto A, Lotti M, Sabri MI, Spencer PS (1987) Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J Neurochem 49: 1515–1522
Moretto A, Lotti M, Spencer PS (1989) In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2 dichlorovinyl phosphate. Arch Toxicol 63: 469–473
Moretto A, Bertolazzi M, Capodicasa E, Peraica M, Richardson RJ, Scapellato ML, Lotti M (1992) Phenylmethanesulfonyl fluoride elicits and intensifies the clinical, expression of neuropathic insults. Arch Toxicol 66: 67–72
Moretto A, Capodicasa E, Peraica M, Lotti M (1993) Phenylmethanesulfonyl fluoride delays recovery from crush of peripheral nerves in hens. Chem-Biol Interact 87: 457–462
Moretto A, Bertolazzi M, Lotti M (1994) The phosphorothioic acid-O-(2-chloro-2,3,3-trifluorocyclobutyl)-O-ethyl S-propyl ester promotes organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicol Appl Pharmacol 129: 133–137
Pope CN, Padilla S (1990) Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol Environ Health 31: 261–273
Rogers TB, Snyder SH (1981) High affinity binding of tetanus toxin to mammalian brain membranes. J Biol Chem 256: 2402–2407
Roberts NL, Fairley C, Phillips C (1983) Screening, acute delayed and subchronic neurotoxicity studies in the hen: measurements and evaluations of clinical signs following administration of TOCP. Neurotoxicology 4: 263–270
Tanaka D Jr, Bursian SJ, Lehning EH, Aulerich RJ (1990) Exposure to triphenyl phosphite results in widespread degeneration in the mammalian central nervous system. Brain Res 53: 250–298
Tanaka D Jr, Bursian SJ, Lehning EH (1992) Neuropathological effects of triphenyl phosphite on the central nervous system of the hen (Gallus domesticus). Fundam Appl Toxicol 18: 72–78
Veronesi B, Dvergsten C (1987) Triphenyl phosphite neuropathy differs from organophosphorus-induced delayed neuropathy in rats. Neuropathol Appl Neurobiol 13: 193–208
Veronesi B, Padilla B, Newland D (1986) Biochemical and neuropathological assessment of triphenyl phosphite in rats. Toxicol Appl Pharmacol 83: 203–210
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fioroni, F., Moretto, A. & Lotti, M. Triphenylphosphite neuropathy in hens. Arch Toxicol 69, 705–711 (1995). https://doi.org/10.1007/s002040050236
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050236